Heaptalk, Jakarta — In commemoration of Breast Cancer Awareness Month in October, Charm, a brand of sanitary pads from Unicharm Indonesia, in collaboration with the Indonesian Breast Cancer Foundation (YKPI), conducted a breast self-examination education program called Sadari for over 400 female students from various junior high and high schools in Jakarta.
“Through education from experts on early breast cancer detection, we hope to contribute to the government’s efforts in nurturing and protecting the future generation of Indonesia,” said Sri Haryani, Director of UniCharm Indonesia, at Balai Komando, East Jakarta, on Wednesday (10/02).
With the slogan ‘Ayo Sadari Setelah Menstruasi,’ translated as Let’s check after menstruation, Sri Haryani hopes this initiative will raise awareness among young women about the importance of making breast self-examination a regular habit after menstruation. This is a crucial step in early breast cancer detection, which can help protect women who are expected to become future leaders of Indonesia.
“In this event, we are not only teaching how to perform breast self-examination but also answering questions from the students through teleconference so that they can gain a basic understanding of breast cancer and tips for early detection,” said Linda Agum Gumelar, Chairperson of the Indonesian Breast Cancer Foundation (YKPI).
In addition to providing education, Charm has added the ‘Ayo Sadari Setelah Menstruasi’ logo to all its product packaging this year as part of its support for this campaign. The logo will also be featured on Charm sanitary pads and CharmNap urinary pads as a further commitment to promoting the Sadari habit.
This event marks the fourth collaboration between Charm and YKPI to celebrate Breast Cancer Awareness Month. It was attended by Charm Brand Ambassador Syifa Hadju and Dr. Iskandar, Sp.B.Subsp.Onk(K), MPH, an oncology surgery specialist from Dharmais Cancer Hospital.
According to data from the Global Cancer Observatory, there were more than 66,000 new breast cancer cases among Indonesian women in 2022, with an incidence rate of 30%. Compared to previous years, the incidence rate has not significantly declined. If not addressed seriously, this number will continue to rise in the coming years.
